Tuesday - April 28, 2026
Goodwin Guides Nektar Therapeutics on its $373.8 Million Underwritten Public Offering, Including Full Exercise of Underwriters' Option to Purchase Additional Shares
April 27, 2026
BOSTON, Massachusetts, April 27 [Category: BizLaw/Legal] -- Goodwin, a law firm, issued the following news release:

* * *

Goodwin Guides Nektar Therapeutics on its $373.8 Million Underwritten Public Offering, Including Full Exercise of Underwriters' Option to Purchase Additional Shares

The Life Sciences team guided Nektar Therapeutics on its underwritten public offering of $373.8 million of shares of its common stock. Nektar sold 4,062,500 shares of co . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products